Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1701231rdf:typepubmed:Citationlld:pubmed
pubmed-article:1701231lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:1701231lifeskim:mentionsumls-concept:C0008659lld:lifeskim
pubmed-article:1701231lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:1701231pubmed:issue10lld:pubmed
pubmed-article:1701231pubmed:dateCreated1991-1-16lld:pubmed
pubmed-article:1701231pubmed:abstractTextThe 17q11-21 chromosomal region is frequently involved in non-random structural rearrangements associated with the M1 and M2 subtypes of acute myeloid leukemias (AML), as well as with the 15;17 translocation typical of the promyelocytic subtype. A number of genes have been localized in this region including the c-erbA-1 and c-erbB-2 proto-oncogenes, the genes coding for the granulocyte-colony stimulating factor (G-CSF), the retinoic acid receptor alpha (RAR alpha) and the myeloperoxidase enzyme (MPO). However, the precise location of these genes in relationship to the 17q11-21 breakpoint(s) has not been determined. Using in situ hybridization on metaphase chromosomes, we established the position of the breakpoints in relationship to the c-erbA-1, c-erbB-2, G-CSF, RAR alpha and MPO loci in a series of AML cases bearing 17q11-21 rearrangements. We report: (i) that the respective position of the five genes is centromere - c-erbA-1 - G-CSF - c-erbB-2 - RAR alpha - MPO - telomere; (ii) that the breakpoints of the various AML subtypes are variably located between the centromere and c-erbB-2 in M1 and M2; (iii) that the breakpoints are consistently located between c-erbB-2 and RAR alpha/MPO in M3; and (iv) that the breakpoint on chromosome 17 in the 15;17 translocation is located on 17q21 and not on 17q11-12 as previously reported.lld:pubmed
pubmed-article:1701231pubmed:languageenglld:pubmed
pubmed-article:1701231pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1701231pubmed:citationSubsetIMlld:pubmed
pubmed-article:1701231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1701231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1701231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1701231pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1701231pubmed:statusMEDLINElld:pubmed
pubmed-article:1701231pubmed:monthOctlld:pubmed
pubmed-article:1701231pubmed:issn0950-9232lld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:LongoLLlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:AvanziGGlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:AlimenaGGlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:GrignaniFFlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:PegoraroLLlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:DontiEElld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:VentiGGlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:PelicciP GPGlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:MencarelliAAlld:pubmed
pubmed-article:1701231pubmed:authorpubmed-author:TabilioAAlld:pubmed
pubmed-article:1701231pubmed:issnTypePrintlld:pubmed
pubmed-article:1701231pubmed:volume5lld:pubmed
pubmed-article:1701231pubmed:geneSymbolc-erbB-2lld:pubmed
pubmed-article:1701231pubmed:geneSymbolc-erbB-1lld:pubmed
pubmed-article:1701231pubmed:ownerNLMlld:pubmed
pubmed-article:1701231pubmed:authorsCompleteYlld:pubmed
pubmed-article:1701231pubmed:pagination1557-63lld:pubmed
pubmed-article:1701231pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:meshHeadingpubmed-meshheading:1701231-...lld:pubmed
pubmed-article:1701231pubmed:year1990lld:pubmed
pubmed-article:1701231pubmed:articleTitleMapping of chromosome 17 breakpoints in acute myeloid leukemias.lld:pubmed
pubmed-article:1701231pubmed:affiliationIstituto di Clinica Medica I, University of Perugia, Policlinico Monteluce, Italy.lld:pubmed
pubmed-article:1701231pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1701231pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1701231lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1701231lld:pubmed